BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

750 related articles for article (PubMed ID: 9127314)

  • 21. Exfoliative cytological assessment of apparently normal buccal mucosa among quid chewers using argyrophilic nucleolar organizer region counts and Papanicolaou staining.
    Mohan BC; Angadi PV
    Acta Cytol; 2013; 57(2):164-70. PubMed ID: 23406917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silver-binding nucleolar organizer regions (AgNORs) in tumors of colon.
    Zaczek M; Dabroś E; Szot W; Chłap Z
    Pol J Pathol; 1996; 47(4):195-200. PubMed ID: 9097712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nucleolar organizer regions (NORs) in adenomyosis.
    Madej P; Plewka A; Madej JA; Plewka D; Rutkowski T
    Pathol Res Pract; 2006; 202(6):433-7. PubMed ID: 16513291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silver-stained nucleolar organizer regions and immunoglobulins in cutaneous squamocellular tumors.
    Aroni K; Mastoraki A; Kyriazi E; Liossi A; Ioannidis E
    Pathol Res Pract; 2007; 203(12):857-62. PubMed ID: 17949923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic and prognostic value of nucleolar organizer regions in normal epithelium, dysplasia, and squamous cell carcinoma of the oral cavity.
    Xie X; Clausen OP; Sudbö J; Boysen M
    Cancer; 1997 Jun; 79(11):2200-8. PubMed ID: 9179068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of AgNOR and Ki-67 antigen as cell kinetic parameters in oral dysplasias and carcinomas.
    Zoeller J; Flentje M; Sinn P; Born IA
    Anal Cell Pathol; 1994 Jul; 7(1):77-88. PubMed ID: 7981138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Argyrophilic nucleolar organizer regions in inflammatory, premalignant, and malignant oral lesions: a quantitative and qualitative assessment.
    Elangovan T; Mani NJ; Malathi N
    Indian J Dent Res; 2008; 19(2):141-6. PubMed ID: 18445932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of fixation and preparation on the AgNOR distribution in routinely processed breast cancer specimens.
    Biesterfeld S; Ruoss E; Hufnagl P; Martin H
    Zentralbl Pathol; 1994 Mar; 140(1):41-8. PubMed ID: 7515672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nucleolar organizer regions in squamous cell carcinoma of the head and neck.
    Hirsch SM; DuCanto J; Caldarelli DD; Hutchinson JC; Coon JS
    Laryngoscope; 1992 Jan; 102(1):39-44. PubMed ID: 1370566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AgNORs in hyperplasia, papilloma and oral squamous cell carcinoma.
    Fonseca LM; do Carmo MA
    Braz Dent J; 2000; 11(2):105-10. PubMed ID: 11210258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silver-binding nucleolar organizing regions: a study of oral leukoplakia and squamous cell carcinoma.
    Chattopadhyay A; Chawda JG; Doshi JJ
    Int J Oral Maxillofac Surg; 1994 Dec; 23(6 Pt 1):374-7. PubMed ID: 7699280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of nucleolar organizer region (NOR) parameters in the uterine leiomyoma.
    Madej P; Madej JA; Plewka A; Kazimierczak W; Dzimira S
    Pathol Res Pract; 2005; 201(8-9):587-92. PubMed ID: 16259112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
    Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
    J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantification of AgNOR expression in exfoliated oral mucosal cells of tobacco chewers with and without lesion.
    Sharma A; Saxena S
    Indian J Dent Res; 2012; 23(2):251-6. PubMed ID: 22945719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Image analysis of AgNORs in esophageal balloon cytosmears].
    Wang DY
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):30-3. PubMed ID: 8334937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral exfoliative cytology of smokers at discrete clinical stages using AgNOR staining.
    Sethi P; Shah PM
    Indian J Dent Res; 2003; 14(3):142-5. PubMed ID: 15164655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AgNOR count as objective marker for dysplastic features in oral leukoplakia.
    Chattopadhyay A; Ray JG; Caplan DJ
    J Oral Pathol Med; 2002 Oct; 31(9):512-7. PubMed ID: 12269989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The overexpression of p53 and proliferative activity in precancerous and cancerous lesions of oral squamous epithelium.
    Ichikawa M; Ishii K; Nakajima T; Mogi K
    J Exp Clin Cancer Res; 1997 Jun; 16(2):141-6. PubMed ID: 9261738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AgNOR distribution in normal and dysplastic laryngeal mucosa and in laryngeal epidermoid carcinomas.
    Mauri FA; Ferrero S; Barbareschi M; Scampini S; Muscarà M; Motta M; Pignataro L
    Pathologica; 1990; 82(1081):493-7. PubMed ID: 1706829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.